Medicus Pharma (MDCX) Shares Fall 24% After Hours: Here's Why

Medicus Pharma Ltd. (NASDAQ:MDCX) shares fell 24.22% to $0.12 in after-hours trading Wednesday after the company announced a 50-to-1 consolidation of its common shares. Medicus Pharma is a biopharmaceutical company. The Share Consolidation The consolidation will take effect Oct. 12, with every 50 common shares automatically exchanged for one new share, according to an SEC filing. The company said the move is intended to raise the bid price of its shares and help it regain compliance with Nasdaq Capital Market’s minimum bid price listing requirement. Shares will begin trading on a consolidated basis on Oct. 12 under a new CUSIP number and ISIN, while the ticker symbol will remain “MDCX.” Shareholders owning shares through a bank, broker or nominee will have their positions automatically adjusted and are not required to take further action. No fractional shares will be issued; holders otherwise entitled to a fractional share will have it rounded down, with cash paid in lieu. Proportionate adjustments will also be made to the exercise price and share count underlying the company’s outstanding equity awards, convertible securities and warrants. Shareholders approved the board’s authority to carry out a consolidation of up to 50-to-1 at the company’s annual meeting on June 3, 2026, with the exact ratio and timing left to the board’s discretion. Read Also: TikTok Allegedly Gave Thousands of Teens and Children Fake Safety Features While Secretly Studying Their Behavior, New York Lawsuit Claims Trading Metrics, Technical Analysis Medicus Pharma has a market capitalization of approximately $10.07 million. Over the past year, Medicus Pharma shares have fallen 93.49%. The stock has traded between a 52-week high of $2.78 and a 52-week low of $0.14. Benzinga’s Edge Stock Rankings show a negative price trend across short-, medium- and long-term time frames. Price Action: In the regular session, Medicus Pharma shares rose 0.63% to close at $0.16 on Wednesday. See More: Top Value Stocks Photo Courtesy: Who is Danny on Shutterstock.com